Zivo Bioscience, Inc.
ZIVO
$17.90
$1.408.49%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -24.31% | -297.78% | 35.20% | 27.73% | 8.95% |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1,372.78% | 12,917.26% | -1.44% | -90.21% | -69.10% |
Change in Net Operating Assets | 120.70% | -95.94% | -89.24% | 684.24% | -258.86% |
Cash from Operations | 44.91% | 36.73% | 20.19% | 50.54% | -32.34% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -100.00% | -14.53% | -- | -- |
Total Debt Repaid | 14.56% | 14.56% | 14.56% | -819.54% | 3.63% |
Issuance of Common Stock | -61.09% | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -63.82% | -38.92% | 190.43% | -253.97% | 1,738.71% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -89.28% | 27.36% | 91.47% | 23.72% | 186.21% |